Pyelonephritis overview

Jump to navigation Jump to search

Urinary Tract Infections Main Page

Pyelonephritis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pyelonephritis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocaridogram

X Ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pyelonephritis overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pyelonephritis overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pyelonephritis overview

CDC on Pyelonephritis overview

Pyelonephritis overview in the news

Blogs on Pyelonephritis overview

Directions to Hospitals Treating Pyelonephritis

Risk calculators and risk factors for Pyelonephritis overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Pyelonephritis is usually an ascending urinary tract infection that has reached the pyelum (pelvis) of the kidney (nephros in Greek). If the infection is severe, the term "urosepsis" is used interchangeably (sepsis being a systemic inflammatory response syndrome due to infection). It requires antibiotics as therapy, and treatment of any underlying causes to prevent recurrence. It is a form of nephritis. It can also be called pyelitis.[1].

Epidemiology and Demographics

The epidemiology and demographics demonstrate that: [2][3][4][5][6][7]

  • Urinary tract infections are the most frequent bacterial infection in women with at least half the women by age 32 report at least one episode.
  • Females are more commonly affected with pyelonephritis than males.
  • Pyelonephritis is not as common as cystitis. The ratio being around 1 is to 28.
  • Pyelonephritis effects 120-130 cases annually per 100,000 women and 30-40 cases per 100,000 men.
  • The incidence of Pyelonephritis in 15-34 year old women is 25 cases per 10,000 women annually .

Historical Perspective

Urinary tract infections have been described since ancient times with the first documented description in the Ebers Papyrus dated to c. 1550 BC. In 1836, Philadelphia surgeon Joseph Parrish published the earliest record of three cases of severe lower urinary tract symptoms without the presence of a bladder stone.[8]

Classification

Pyelonephritis can be classified based on the duration of infection and the aetiology into the following categories.[9][10]

  • Acute complicated pyelonephritis
  • Acute Complicated Pyelonephritis
  • Chronic Pyelonephritis
  • Emphysematous Pyelonephritis
  • Xanthogranulomatous Pyelonephritis

Pathophysiology

Pyelonephritis results from infection of the renal parenchyma that can result either from an ascending infection from the urethra, bladder or ureter or by a descending infection or atonement of the infection from the blood. Immunosuppressed patients of any kind are more prone to getting infections and thus pyelonephritis.[11][12]

Causes

Most of cases of Pyelonephritis are caused by escherichia coli ("E. coli"), a bacterium found in the lower gastrointestinal tract. Other causes of Pyelonephritis include medications, diabetes, Crohn's disease, iatrogenic causes, endometriosis, pelvic inflammatory disease, urinary obstruction, and bladder incontinence.[12][13]

Differential Diagnosis

Cystitis must be differentiated from other causes of dysuria such as Cystitis, urethritis, prostatitis, vulvovaginitis, urethral strictures or diverticula, benign prostatic hyperplasia and neoplasms such as renal cell carcinoma and cancers of the bladder, prostate, and penis.[4][14]

Risk Factors

Common risk factors in the development of pyelonephritis include urinary catheters, bladder stones, diabetes, pregnancy, catheterization, bowel incontinence, old age, and immobility.[12]

Natural History, Complications, and Prognosis

Pyelonephritis has to be treated with medications immediately after drawing urine samples. Many complications can result as a result of Pyelonephritis and include, Sepsis, Pyonephrosis, perinephric abscess, renal failure and even death.

Diagnosis

History and Symptoms

A detailed history is the most important step to begin dealing with any medical condition. Patients with Pyelonephritis have a typical history of fever, dysuria and flank pain.

Physical Examination

Laboratory Findings

Urinalysis and urine culture is done to help diagnose pyelonephritis on first interaction. A combination of leukocyte esterase test and nitrite test (with either of the two test being positive) is considered to be very effective with a sensitivity ranging from 75-84 and a specificity ranging from 82-98 percent.[12]

Treatment

Medical Treatment

Treatment of Pyelonephritis is usually medical. In case of any risk factors like catheters or obstructing stones or masses, the management includes removing the risk factors to prevent further progress of the disease and the pathogen accumulation.

Surgery

In recurrent infections, additional investigations may identify an underlying abnormality. Occasionally, surgical intervention is necessary to improve chances of recurrence.

References

  1. Ramakrishnan K, Scheid DC (2005). "Diagnosis and management of acute pyelonephritis in adults". Am Fam Physician. 71 (5): 933–42. PMID 15768623.
  2. Foxman B, Brown P (2003). "Epidemiology of urinary tract infections: transmission and risk factors, incidence, and costs". Infect Dis Clin North Am. 17 (2): 227–41. PMID 12848468.
  3. Czaja CA, Scholes D, Hooton TM, Stamm WE (2007). "Population-based epidemiologic analysis of acute pyelonephritis". Clin. Infect. Dis. 45 (3): 273–80. doi:10.1086/519268. PMID 17599303.
  4. 4.0 4.1 Kurowski K (1998). "The woman with dysuria". Am Fam Physician. 57 (9): 2155–64, 2169–70. PMID 9606306.
  5. Hooton TM, Besser R, Foxman B, Fritsche TR, Nicolle LE (2004). "Acute uncomplicated cystitis in an era of increasing antibiotic resistance: a proposed approach to empirical therapy". Clin Infect Dis. 39 (1): 75–80. doi:10.1086/422145. PMID 15206056.
  6. Ikäheimo R, Siitonen A, Heiskanen T, Kärkkäinen U, Kuosmanen P, Lipponen P; et al. (1996). "Recurrence of urinary tract infection in a primary care setting: analysis of a 1-year follow-up of 179 women". Clin Infect Dis. 22 (1): 91–9. PMID 8824972.
  7. Czaja CA, Scholes D, Hooton TM, Stamm WE (2007). "Population-based epidemiologic analysis of acute pyelonephritis". Clin Infect Dis. 45 (3): 273–80. doi:10.1086/519268. PMID 17599303.
  8. Interstitial Cystitis. Wikipedia.https://en.wikipedia.org/wiki/Interstitial_cystitis#History Accessed on February 8, 2016
  9. Wang HD, Zhu XF, Xu X, Li GZ, Liu N, He F; et al. (2017). "Emphysematous Pyelonephritis Treated with Vacuum Sealing Drainage". Chin Med J (Engl). 130 (2): 247–248. doi:10.4103/0366-6999.198021. PMID 28091422.
  10. Upasani A, Barnacle A, Roebuck D, Cherian A (2016). "Combination of Surgical Drainage and Renal Artery Embolization: An Alternative Treatment for Xanthogranulomatous Pyelonephritis". Cardiovasc Intervent Radiol. doi:10.1007/s00270-016-1522-z. PMID 28028578.
  11. Hooton TM (2000). "Pathogenesis of urinary tract infections: an update". J Antimicrob Chemother. 46 Suppl A: 1–7. PMID 10969044.
  12. 12.0 12.1 12.2 12.3 Ramakrishnan K, Scheid DC (2005). "Diagnosis and management of acute pyelonephritis in adults". Am Fam Physician. 71 (5): 933–42. PMID 15768623.
  13. Stamm WE, Hooton TM (1993). "Management of urinary tract infections in adults". N Engl J Med. 329 (18): 1328–34. doi:10.1056/NEJM199310283291808. PMID 8413414.
  14. Bremnor JD, Sadovsky R (2002). "Evaluation of dysuria in adults". Am Fam Physician. 65 (8): 1589–96. PMID 11989635.

Template:WH Template:WS